Litigation Details for Senju Pharmaceutical Co. Ltd. v. Aurobindo Pharma Ltd. (D. Del. 2014)

✉ Email this page to a colleague

The small molecule drugs covered by the patent cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2014-05-02	1		infringement of Reexamined United States Patent No. 6,333,045 (“the ‘045 patent”). The infringement …review pharmaceutical patents and seek opportunities to challenge those patents. …expiration of a listed patent to provide notice to the owner of the listed patent(s) and to the NDA holder…of the ‘045 patent. 35. Defendants were necessarily aware of the patent-in-suit when…the ‘045 patent is an act of infringement of Claims 6, 12, 14, 15 and 16 of the ‘045 patent reexamination	External link to document
2015-03-30	20		reexamined United States Patent No. 6,333,045 ("the '045 patent"). (D.I. 1) On August… state a claim for relief of patent infringement with an invalid patent." (D.I. 14 at 4) By a decision…on this court's finding that the '045 patent is invalid, 1 arguing that "[a] plaintiff …2014 30 March 2015 1:14-cv-00579 830 Patent None District Court, D. Delaware	External link to document
2015-03-30	21		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,333,045 B1/C1. (Attachments…2014 30 March 2015 1:14-cv-00579 830 Patent None District Court, D. Delaware	External link to document
2014-05-02	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,333,045 B1 / C1;. (cla, ) (…2014 30 March 2015 1:14-cv-00579 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document